These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18022929)

  • 1. Determination of urinary enzymes as a marker of early renal damage in diabetic patients.
    Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Hosseini R
    J Clin Lab Anal; 2007; 21(6):413-7. PubMed ID: 18022929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.
    Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A
    J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Kim JH; Lee BW
    Medicine (Baltimore); 2016 Jul; 95(27):e4114. PubMed ID: 27399115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary N-acetyl-beta-D-glucosaminidase in children with diabetes as an early marker of diabetic nephropathy.
    Abdel Shakour S; el-Hefnawy H; el-Yamani MY; Azmi Y
    East Mediterr Health J; 2002 Jan; 8(1):24-30. PubMed ID: 15330557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
    Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
    Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for tubular dysfunction in insulin dependent diabetes.
    Ratzmann KP; Schimke E; Jung K; Pergande M
    J Diabet Complications; 1989; 3(3):167-71. PubMed ID: 2528561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary N-acetyl-beta-D-glucosaminidase activity does not predict development of diabetic nephropathy.
    Agardh CD; Tallroth G; Hultberg B
    Diabetes Care; 1987; 10(5):604-6. PubMed ID: 3677979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N; Hara H; Okamura M; Egusa G; Yamakido M
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
    Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C
    Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary N-acetyl-beta-glucosaminidase activity in type I diabetes mellitus.
    Jones AP; Lock S; Griffiths KD
    Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():58-62. PubMed ID: 7762951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of urinary enzymes in diabetic nephropathy.
    Morita E; Kaizu K; Uriu K; Hashimoto O; Komine N; Eto S
    J Diabet Complications; 1991; 5(2-3):158-9. PubMed ID: 1685160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
    Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
    Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of urinary enzymes for diabetes mellitus and hypertension.
    Ishii N; Ogawa Z; Itoh H; Ikenaga H; Saruta T
    Enzyme Protein; 1994-1995; 48(3):174-82. PubMed ID: 8589804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control.
    Watts GF; Vlitos MA; Morris RW; Price RG
    Diabete Metab; 1988; 14(5):653-8. PubMed ID: 3234588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.